Oncology Precision Medicine Market Size, Trends, and Growth Analysis 2026-2033 The Oncology Precision Medicine industry has emerged as a critical frontier in cancer care, driven by breakthroughs in genomics and targeted therapies. This market is poised for robust expansion given the rising incidence of cancer and the paradigm shift towards personalized treatment approaches that enhance efficacy and minimize adverse effects. Market Size and Overview The Global Oncology Precision Medicine Market is estimated to be valued at USD 153.81 billion in 2025 and is expected to reach USD 281.17 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.00% from 2025 to 2032. https://www.coherentmi.com/industry-reports/oncology-precision-medicine-market